Trial intelligence / Profile preview

Black Seed Oil in Type 2 Diabetes Mellitus

NCT03959306Phase 2Unknown

Sponsor
Ain Shams University
Start
Apr 2019
Primary completion
Aug 2019
Countries
1
01

Overview

Phase 2, randomised, open-label trial in type 2 diabetes mellitus (T2DM), sponsored by Ain Shams University. Primary endpoint: soluble intercellular adhesion molecule at 3 months. Status: unknown.

02

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT03959306.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03959306.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call